Ling‐Wen Ding

6.2k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Ling‐Wen Ding is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling‐Wen Ding has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Ling‐Wen Ding's work include Cancer-related gene regulation (8 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related molecular mechanisms research (7 papers). Ling‐Wen Ding is often cited by papers focused on Cancer-related gene regulation (8 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related molecular mechanisms research (7 papers). Ling‐Wen Ding collaborates with scholars based in Singapore, China and United States. Ling‐Wen Ding's co-authors include H. Phillip Koeffler, De‐Chen Lin, Boon Cher Goh, Anand Mayakonda, Qiao‐Yang Sun, Lingzhi Wang, Xiaoqiang Xiang, Paul C. Ho, Wenwen Chien and Pei Shi Ong and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Ling‐Wen Ding

60 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resveratrol for cancer therapy: Challenges and future perspectives

2021 334 citations Ling‐Wen Ding, Xiaoqiang Xiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling‐Wen Ding Singapore	29	1.6k	541	506	318	260	65	2.4k
Chern Ein Oon Malaysia	23	1.6k 1.0×	682 1.3×	533 1.1×	220 0.7×	225 0.9×	71	2.8k
In‐Chul Park South Korea	32	1.8k 1.1×	589 1.1×	543 1.1×	256 0.8×	228 0.9×	116	2.8k
Yanping Xu China	22	1.7k 1.0×	552 1.0×	587 1.2×	299 0.9×	337 1.3×	46	2.7k
Zhenyi Su China	16	1.4k 0.9×	714 1.3×	408 0.8×	327 1.0×	291 1.1×	31	2.2k
Mohamed Ali‐Seyed Saudi Arabia	20	1.6k 1.0×	400 0.7×	891 1.8×	429 1.3×	197 0.8×	44	2.7k
Miao Yin China	27	1.3k 0.8×	603 1.1×	330 0.7×	159 0.5×	263 1.0×	83	2.4k
Ernesto Yagüe United Kingdom	30	1.6k 1.0×	632 1.2×	830 1.6×	147 0.5×	110 0.4×	60	2.5k
Jingxuan Pan China	38	2.7k 1.7×	795 1.5×	1.0k 2.0×	284 0.9×	409 1.6×	90	4.1k
Helena Pópulo Portugal	13	1.2k 0.7×	344 0.6×	518 1.0×	188 0.6×	250 1.0×	21	1.9k

Countries citing papers authored by Ling‐Wen Ding

Since Specialization

Citations

This map shows the geographic impact of Ling‐Wen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Wen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Wen Ding more than expected).

Fields of papers citing papers by Ling‐Wen Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Wen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Wen Ding. The network helps show where Ling‐Wen Ding may publish in the future.

Co-authorship network of co-authors of Ling‐Wen Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Wen Ding. A scholar is included among the top collaborators of Ling‐Wen Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Wen Ding. Ling‐Wen Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ying, Ou Xu, Yibin Liu, et al.. (2025). Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation. ACS Applied Materials & Interfaces. 17(40). 55861–55875.

Li, Zheng, Guodong Ren, Xuewei Wang, et al.. (2025). Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy. Biomaterials. 322. 123387–123387. 9 indexed citations

Zhang, Miao, Yongling Wang, Benhao Li, et al.. (2025). STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy (Adv. Mater. 10/2025). Advanced Materials. 37(10). 1 indexed citations

Ding, Ling‐Wen, Jia Li, Benedict Yan, et al.. (2024). A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical Cancer Research. 30(10). 2170–2180. 1 indexed citations

Liu, Jianping, Ye Zhang, Yingbo Jia, et al.. (2024). Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy. Angewandte Chemie. 136(10). 5 indexed citations

Wang, Rong, Lan Zhang, Jun Wang, et al.. (2024). Prebiotic stachyose inhibits PRDX5 activity and castration-resistant prostate cancer development. International Journal of Biological Macromolecules. 278(Pt 3). 134844–134844. 2 indexed citations

Ding, Ling‐Wen, Henry Yang, Jonathan W. Said, et al.. (2023). Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. Cancer Research. 83(6). 922–938. 12 indexed citations

Ma, Sai, Bo Zhou, Qian Yang, et al.. (2021). A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma. Cancer Research. 81(5). 1216–1229. 60 indexed citations

Ke, Xinyu, Ye Chen, Ruby Yu‐Tong Lin, et al.. (2021). MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma. Oncogene. 40(10). 1851–1867. 16 indexed citations

10.

Shi, Xianping, Yueyuan Zheng, Bo Zhou, et al.. (2020). EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma. Nucleic Acids Research. 48(20). 11434–11451. 26 indexed citations

11.

Pan, Jian, Tiago C. Silva, Nicole Gull, et al.. (2020). Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas. Cancer Research. 80(13). 2722–2736. 38 indexed citations

12.

Ding, Ling‐Wen, Qiao‐Yang Sun, Jarem Edwards, et al.. (2019). LNK suppresses interferon signaling in melanoma. Nature Communications. 10(1). 2230–2230. 20 indexed citations

13.

Zhang, Yin, Anand Mayakonda, Vikas Madan, et al.. (2018). ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer. Oncogene. 37(45). 5939–5951. 23 indexed citations

14.

Chien, Wenwen, Makoto Sudo, Ling‐Wen Ding, et al.. (2018). Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib. Journal of Cancer. 9(24). 4762–4773. 28 indexed citations

15.

Lin, De‐Chen, Anand Mayakonda, Huy Q. Dinh, et al.. (2017). Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. Cancer Research. 77(9). 2255–2265. 148 indexed citations

16.

Jiang, Yuan, Anand Mayakonda, Moli Huang, et al.. (2017). Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma. Cancer Research. 77(23). 6614–6626. 77 indexed citations

17.

Takao, Sumiko, Wenwen Chien, Vikas Madan, et al.. (2017). Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia. Leukemia. 32(3). 616–625. 30 indexed citations

18.

Lin, De‐Chen, Liang Xu, Ye Chen, et al.. (2015). Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma. Cancer Research. 75(9). 1815–1827. 51 indexed citations

19.

Ding, Ling‐Wen, Qiao‐Yang Sun, Wenwen Chien, et al.. (2014). LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene. 34(11). 1463–1474. 20 indexed citations

20.

Hayano, Takahide, Manoj Garg, Dong Yin, et al.. (2013). SOX7 is down-regulated in lung cancer. Journal of Experimental & Clinical Cancer Research. 32(1). 17–17. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact